| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| E-Selectin | 30 | 2022 | 576 | 6.110 |
Why?
|
| Fucose | 13 | 2022 | 115 | 2.680 |
Why?
|
| Mesenchymal Stem Cells | 14 | 2024 | 1663 | 2.230 |
Why?
|
| Fucosyltransferases | 12 | 2022 | 118 | 2.210 |
Why?
|
| Cell Movement | 28 | 2019 | 5194 | 2.080 |
Why?
|
| L-Selectin | 16 | 2017 | 212 | 2.020 |
Why?
|
| Glycosyltransferases | 7 | 2018 | 114 | 1.950 |
Why?
|
| Glycomics | 5 | 2019 | 118 | 1.770 |
Why?
|
| Polysaccharides | 13 | 2021 | 1016 | 1.630 |
Why?
|
| Ligands | 31 | 2022 | 3273 | 1.590 |
Why?
|
| Hematopoietic Stem Cells | 23 | 2017 | 3401 | 1.390 |
Why?
|
| Cell Adhesion | 27 | 2022 | 3089 | 1.290 |
Why?
|
| Selectins | 5 | 2016 | 101 | 1.030 |
Why?
|
| Lymphocytes | 16 | 2008 | 2599 | 1.010 |
Why?
|
| T-Lymphocytes | 15 | 2022 | 10261 | 0.840 |
Why?
|
| Glycoproteins | 7 | 2023 | 2195 | 0.810 |
Why?
|
| Endothelial Cells | 6 | 2022 | 3584 | 0.800 |
Why?
|
| Bone Marrow Cells | 8 | 2017 | 2412 | 0.760 |
Why?
|
| Membrane Glycoproteins | 13 | 2018 | 3690 | 0.750 |
Why?
|
| Glycosylation | 11 | 2024 | 1100 | 0.740 |
Why?
|
| Glycopeptides | 1 | 2022 | 224 | 0.730 |
Why?
|
| Tongue Neoplasms | 1 | 2023 | 187 | 0.730 |
Why?
|
| Myeloid Cells | 3 | 2014 | 839 | 0.720 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 7 | 2014 | 633 | 0.710 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2023 | 1192 | 0.650 |
Why?
|
| Blotting, Western | 7 | 2015 | 5020 | 0.610 |
Why?
|
| Heparitin Sulfate | 2 | 2018 | 223 | 0.610 |
Why?
|
| Neuraminidase | 5 | 2017 | 190 | 0.600 |
Why?
|
| Oligosaccharides | 2 | 2018 | 406 | 0.600 |
Why?
|
| Chemotaxis, Leukocyte | 6 | 2020 | 657 | 0.580 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2018 | 100 | 0.570 |
Why?
|
| Cell Communication | 5 | 2021 | 1660 | 0.550 |
Why?
|
| Leukocytes | 6 | 2020 | 2027 | 0.540 |
Why?
|
| Protein Engineering | 4 | 2019 | 550 | 0.540 |
Why?
|
| P-Selectin | 7 | 2009 | 597 | 0.540 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 3 | 2018 | 504 | 0.530 |
Why?
|
| Immunologic Surveillance | 1 | 2017 | 92 | 0.530 |
Why?
|
| Biotechnology | 1 | 2018 | 284 | 0.530 |
Why?
|
| Bone Marrow Transplantation | 12 | 2004 | 2729 | 0.510 |
Why?
|
| Leukocytes, Mononuclear | 4 | 2018 | 1857 | 0.500 |
Why?
|
| Chemokines | 5 | 2018 | 956 | 0.490 |
Why?
|
| Head and Neck Neoplasms | 3 | 2023 | 2921 | 0.490 |
Why?
|
| Graft vs Host Disease | 13 | 2020 | 3078 | 0.480 |
Why?
|
| Skin | 8 | 2004 | 4489 | 0.470 |
Why?
|
| Models, Immunological | 1 | 2017 | 517 | 0.470 |
Why?
|
| Acetylglucosamine | 3 | 2009 | 190 | 0.450 |
Why?
|
| Receptors, Lymphocyte Homing | 5 | 2005 | 141 | 0.430 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2014 | 51 | 0.430 |
Why?
|
| Mechanical Phenomena | 1 | 2015 | 141 | 0.430 |
Why?
|
| Endothelium, Vascular | 7 | 2009 | 4427 | 0.430 |
Why?
|
| Isoenzymes | 1 | 2018 | 1689 | 0.420 |
Why?
|
| Cell Adhesion Molecules | 6 | 2006 | 1612 | 0.420 |
Why?
|
| Hematopoiesis | 6 | 2022 | 2058 | 0.420 |
Why?
|
| Chemokine CXCL12 | 4 | 2009 | 455 | 0.420 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2020 | 1811 | 0.400 |
Why?
|
| Leukocytosis | 1 | 2014 | 248 | 0.400 |
Why?
|
| Endothelium | 7 | 2020 | 767 | 0.390 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 1 | 2012 | 89 | 0.390 |
Why?
|
| Bone and Bones | 2 | 2016 | 2554 | 0.390 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2014 | 437 | 0.390 |
Why?
|
| Immunotherapy, Adoptive | 2 | 2019 | 1510 | 0.390 |
Why?
|
| Cell Line | 14 | 2020 | 15543 | 0.390 |
Why?
|
| Glycoconjugates | 3 | 2022 | 87 | 0.390 |
Why?
|
| Transplantation, Heterologous | 11 | 2016 | 2394 | 0.380 |
Why?
|
| Chemokine CCL5 | 2 | 2009 | 213 | 0.380 |
Why?
|
| Animals | 68 | 2022 | 168764 | 0.380 |
Why?
|
| T-Lymphocytes, Regulatory | 3 | 2020 | 3111 | 0.370 |
Why?
|
| Antigens, CD34 | 3 | 2011 | 656 | 0.370 |
Why?
|
| Neoplastic Stem Cells | 4 | 2021 | 1352 | 0.370 |
Why?
|
| Peroxidase | 1 | 2014 | 606 | 0.370 |
Why?
|
| Monocytes | 2 | 2018 | 2595 | 0.340 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 21 | 2022 | 5753 | 0.330 |
Why?
|
| CHO Cells | 6 | 2015 | 1372 | 0.330 |
Why?
|
| Career Choice | 1 | 2016 | 769 | 0.330 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2015 | 820 | 0.330 |
Why?
|
| Dendritic Cells | 2 | 2018 | 2747 | 0.320 |
Why?
|
| Cells, Cultured | 13 | 2020 | 18973 | 0.320 |
Why?
|
| Cricetinae | 6 | 2015 | 2411 | 0.310 |
Why?
|
| Humans | 118 | 2024 | 765968 | 0.310 |
Why?
|
| Neoplasm Proteins | 3 | 2011 | 3596 | 0.310 |
Why?
|
| Graft vs Tumor Effect | 2 | 2006 | 70 | 0.300 |
Why?
|
| Protein Binding | 7 | 2019 | 9296 | 0.300 |
Why?
|
| Chemotaxis | 2 | 2009 | 596 | 0.300 |
Why?
|
| Bioethics | 1 | 2010 | 119 | 0.300 |
Why?
|
| Gene Expression Regulation | 8 | 2020 | 11888 | 0.300 |
Why?
|
| Neural Stem Cells | 1 | 2015 | 898 | 0.290 |
Why?
|
| Insulin-Secreting Cells | 1 | 2015 | 898 | 0.290 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2008 | 95 | 0.290 |
Why?
|
| Hyaluronic Acid | 2 | 2018 | 484 | 0.280 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2023 | 4044 | 0.280 |
Why?
|
| Cell Differentiation | 9 | 2021 | 11641 | 0.280 |
Why?
|
| Colonic Neoplasms | 4 | 2008 | 2531 | 0.280 |
Why?
|
| Fetal Blood | 2 | 2022 | 1369 | 0.270 |
Why?
|
| Mice | 32 | 2022 | 81819 | 0.260 |
Why?
|
| Leukocyte Rolling | 2 | 2005 | 69 | 0.260 |
Why?
|
| Multipotent Stem Cells | 1 | 2008 | 199 | 0.260 |
Why?
|
| Integrin alpha4beta1 | 3 | 2011 | 119 | 0.260 |
Why?
|
| Peripheral Blood Stem Cell Transplantation | 2 | 2004 | 266 | 0.250 |
Why?
|
| Coculture Techniques | 5 | 2018 | 1336 | 0.240 |
Why?
|
| Lymph Nodes | 9 | 2008 | 3454 | 0.240 |
Why?
|
| Developmental Disabilities | 1 | 2014 | 1519 | 0.240 |
Why?
|
| Mice, Inbred NOD | 3 | 2019 | 1837 | 0.230 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2011 | 950 | 0.230 |
Why?
|
| Neoplasms | 6 | 2021 | 22340 | 0.230 |
Why?
|
| Transplantation Immunology | 2 | 2006 | 541 | 0.230 |
Why?
|
| Immunophenotyping | 4 | 2018 | 1866 | 0.230 |
Why?
|
| Stress, Physiological | 2 | 2009 | 1402 | 0.220 |
Why?
|
| Stress, Mechanical | 4 | 2015 | 1668 | 0.220 |
Why?
|
| Bone Marrow | 3 | 2016 | 2921 | 0.210 |
Why?
|
| Dermatitis, Contact | 1 | 2003 | 135 | 0.210 |
Why?
|
| Stromal Cells | 2 | 2008 | 1329 | 0.210 |
Why?
|
| N-Acetylneuraminic Acid | 3 | 2016 | 175 | 0.210 |
Why?
|
| Orosomucoid | 1 | 2022 | 47 | 0.210 |
Why?
|
| Gene Expression Regulation, Neoplastic | 3 | 2011 | 8611 | 0.210 |
Why?
|
| Transplantation Conditioning | 10 | 2005 | 1635 | 0.200 |
Why?
|
| Biological Assay | 1 | 2006 | 627 | 0.200 |
Why?
|
| Methylprednisolone | 2 | 1995 | 386 | 0.200 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 1241 | 0.200 |
Why?
|
| Cell Line, Tumor | 8 | 2021 | 17075 | 0.200 |
Why?
|
| Transplantation, Homologous | 14 | 2020 | 4860 | 0.200 |
Why?
|
| Neutrophils | 2 | 2016 | 3776 | 0.190 |
Why?
|
| Immunotherapy | 2 | 2018 | 4752 | 0.190 |
Why?
|
| Ions | 1 | 2022 | 254 | 0.190 |
Why?
|
| Mucins | 2 | 2023 | 567 | 0.190 |
Why?
|
| Protein Processing, Post-Translational | 5 | 2021 | 1957 | 0.190 |
Why?
|
| N-Acetylglucosaminyltransferases | 1 | 2022 | 168 | 0.180 |
Why?
|
| Research | 1 | 2010 | 1975 | 0.180 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 3 | 2006 | 379 | 0.180 |
Why?
|
| Cryopreservation | 3 | 2024 | 728 | 0.180 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2015 | 3446 | 0.170 |
Why?
|
| Flow Cytometry | 7 | 2018 | 5881 | 0.170 |
Why?
|
| Cricetulus | 2 | 2015 | 805 | 0.170 |
Why?
|
| Immunomodulation | 1 | 2024 | 547 | 0.170 |
Why?
|
| GATA3 Transcription Factor | 1 | 2020 | 163 | 0.170 |
Why?
|
| Galectins | 1 | 2022 | 294 | 0.160 |
Why?
|
| Purpura, Thrombotic Thrombocytopenic | 1 | 2001 | 132 | 0.160 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 1 | 2020 | 151 | 0.160 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 5 | 2004 | 227 | 0.160 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 5 | 2005 | 894 | 0.160 |
Why?
|
| Polydeoxyribonucleotides | 1 | 2020 | 136 | 0.160 |
Why?
|
| Fibronectins | 3 | 2017 | 719 | 0.160 |
Why?
|
| Drug Repositioning | 1 | 2021 | 246 | 0.160 |
Why?
|
| Thrombocytopenia | 4 | 2022 | 1171 | 0.150 |
Why?
|
| Leukemia | 2 | 2022 | 1522 | 0.150 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 2 | 2011 | 694 | 0.150 |
Why?
|
| Testis | 1 | 2022 | 780 | 0.150 |
Why?
|
| Transplantation Chimera | 5 | 2005 | 609 | 0.150 |
Why?
|
| Immune Tolerance | 4 | 2020 | 2324 | 0.150 |
Why?
|
| Amino Sugars | 1 | 2018 | 39 | 0.150 |
Why?
|
| Cell Survival | 4 | 2018 | 5747 | 0.150 |
Why?
|
| Shear Strength | 2 | 2009 | 160 | 0.150 |
Why?
|
| Epigenesis, Genetic | 1 | 2011 | 3819 | 0.150 |
Why?
|
| Cation Transport Proteins | 1 | 2020 | 325 | 0.140 |
Why?
|
| Neoplasm Metastasis | 4 | 2019 | 4893 | 0.140 |
Why?
|
| Major Histocompatibility Complex | 4 | 1985 | 879 | 0.140 |
Why?
|
| Exanthema | 1 | 2002 | 502 | 0.140 |
Why?
|
| Stem Cells | 2 | 2010 | 3540 | 0.140 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 2020 | 1347 | 0.140 |
Why?
|
| Prostaglandins F | 1 | 2017 | 79 | 0.140 |
Why?
|
| Manganese | 1 | 2020 | 395 | 0.140 |
Why?
|
| Click Chemistry | 1 | 2018 | 100 | 0.140 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2022 | 1151 | 0.140 |
Why?
|
| Hedgehog Proteins | 1 | 2022 | 774 | 0.140 |
Why?
|
| Papio | 8 | 2002 | 671 | 0.140 |
Why?
|
| Mice, SCID | 2 | 2019 | 2630 | 0.140 |
Why?
|
| Acute Disease | 6 | 2020 | 7232 | 0.140 |
Why?
|
| Thoracic Duct | 2 | 1995 | 71 | 0.140 |
Why?
|
| Antigens, Surface | 3 | 2001 | 1617 | 0.130 |
Why?
|
| Transfection | 4 | 2016 | 5743 | 0.130 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2021 | 1167 | 0.130 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 2005 | 1724 | 0.130 |
Why?
|
| Cell Membrane | 2 | 2016 | 3634 | 0.130 |
Why?
|
| Extravasation of Diagnostic and Therapeutic Materials | 1 | 2016 | 101 | 0.130 |
Why?
|
| Education, Professional | 1 | 2016 | 53 | 0.120 |
Why?
|
| Intracellular Space | 1 | 2016 | 198 | 0.120 |
Why?
|
| Vulnerable Populations | 1 | 2021 | 718 | 0.120 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2015 | 122 | 0.120 |
Why?
|
| Up-Regulation | 2 | 2014 | 4137 | 0.120 |
Why?
|
| Thrombosis | 4 | 2001 | 2949 | 0.120 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2018 | 691 | 0.120 |
Why?
|
| Receptors, CXCR4 | 2 | 2011 | 728 | 0.120 |
Why?
|
| Needs Assessment | 1 | 2021 | 1138 | 0.120 |
Why?
|
| Hematologic Neoplasms | 7 | 2005 | 1927 | 0.120 |
Why?
|
| Extracellular Space | 1 | 2016 | 563 | 0.110 |
Why?
|
| Immunosuppressive Agents | 4 | 2006 | 4209 | 0.110 |
Why?
|
| Receptors, Antigen, T-Cell | 2 | 2017 | 2570 | 0.110 |
Why?
|
| Mice, Knockout | 3 | 2019 | 14448 | 0.110 |
Why?
|
| Mice, Inbred C57BL | 6 | 2016 | 22332 | 0.110 |
Why?
|
| Tumor Escape | 1 | 2017 | 371 | 0.110 |
Why?
|
| Biocatalysis | 1 | 2014 | 167 | 0.110 |
Why?
|
| Immune System Diseases | 1 | 2016 | 251 | 0.110 |
Why?
|
| Cell Lineage | 2 | 2020 | 2573 | 0.110 |
Why?
|
| Immunologic Memory | 1 | 2020 | 1375 | 0.110 |
Why?
|
| Lymphocyte Activation | 2 | 2020 | 5501 | 0.110 |
Why?
|
| Kinetics | 5 | 2016 | 6274 | 0.110 |
Why?
|
| Autoimmunity | 1 | 2021 | 1354 | 0.100 |
Why?
|
| RNA, Messenger | 2 | 2018 | 12768 | 0.100 |
Why?
|
| Vaccines | 1 | 2021 | 841 | 0.100 |
Why?
|
| Antigens, CD1 | 2 | 2008 | 435 | 0.100 |
Why?
|
| Receptors, Cell Surface | 2 | 1993 | 2817 | 0.100 |
Why?
|
| Antigens | 1 | 2018 | 1438 | 0.100 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2018 | 4348 | 0.100 |
Why?
|
| Organ Specificity | 1 | 2017 | 1965 | 0.100 |
Why?
|
| Epitopes | 3 | 2008 | 2523 | 0.100 |
Why?
|
| Structure-Activity Relationship | 2 | 2011 | 3051 | 0.100 |
Why?
|
| Refrigeration | 1 | 2011 | 27 | 0.100 |
Why?
|
| Molecular Weight | 1 | 2014 | 2163 | 0.100 |
Why?
|
| Antigens, Neoplasm | 4 | 2005 | 2002 | 0.100 |
Why?
|
| Chemokines, CXC | 2 | 2006 | 416 | 0.100 |
Why?
|
| Skull | 1 | 2016 | 811 | 0.100 |
Why?
|
| Metalloproteases | 1 | 2011 | 61 | 0.090 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2021 | 1560 | 0.090 |
Why?
|
| Benzylamines | 2 | 2009 | 251 | 0.090 |
Why?
|
| Peptides | 2 | 2022 | 4331 | 0.090 |
Why?
|
| Heterocyclic Compounds | 2 | 2009 | 245 | 0.090 |
Why?
|
| Lymphopenia | 1 | 1993 | 297 | 0.090 |
Why?
|
| Bioengineering | 1 | 2012 | 97 | 0.090 |
Why?
|
| Psoriasis | 2 | 1989 | 919 | 0.090 |
Why?
|
| Body Size | 1 | 2014 | 459 | 0.090 |
Why?
|
| Biomedical Research | 2 | 2017 | 3458 | 0.090 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 1652 | 0.090 |
Why?
|
| Blood Platelets | 2 | 2011 | 2464 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2018 | 2194 | 0.090 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 2476 | 0.090 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2018 | 1083 | 0.090 |
Why?
|
| HL-60 Cells | 2 | 2001 | 364 | 0.090 |
Why?
|
| Organ Transplantation | 2 | 2016 | 1174 | 0.090 |
Why?
|
| Lymphocyte Depletion | 4 | 2006 | 605 | 0.090 |
Why?
|
| Extracellular Matrix | 1 | 2018 | 1727 | 0.080 |
Why?
|
| Adult Stem Cells | 1 | 2012 | 221 | 0.080 |
Why?
|
| Complement C4 | 3 | 1985 | 208 | 0.080 |
Why?
|
| Colitis | 1 | 2018 | 1239 | 0.080 |
Why?
|
| Small Molecule Libraries | 1 | 2015 | 741 | 0.080 |
Why?
|
| History, 21st Century | 1 | 2016 | 1574 | 0.080 |
Why?
|
| Mutation | 1 | 2014 | 30198 | 0.080 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2011 | 246 | 0.080 |
Why?
|
| Microscopy | 1 | 2015 | 901 | 0.080 |
Why?
|
| Nerve Regeneration | 1 | 2015 | 802 | 0.080 |
Why?
|
| Interleukin-2 | 3 | 2003 | 1896 | 0.080 |
Why?
|
| Sialic Acids | 2 | 2000 | 119 | 0.080 |
Why?
|
| Chondroitin Sulfates | 1 | 2009 | 173 | 0.080 |
Why?
|
| Endothelium, Lymphatic | 1 | 1988 | 63 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 8 | 2008 | 9249 | 0.080 |
Why?
|
| Pluripotent Stem Cells | 1 | 2015 | 807 | 0.080 |
Why?
|
| Transplantation, Autologous | 6 | 2004 | 2120 | 0.070 |
Why?
|
| Complement Factor B | 2 | 1985 | 56 | 0.070 |
Why?
|
| Peyer's Patches | 1 | 1988 | 120 | 0.070 |
Why?
|
| Regenerative Medicine | 1 | 2011 | 303 | 0.070 |
Why?
|
| Lymph | 1 | 2008 | 78 | 0.070 |
Why?
|
| History, 20th Century | 1 | 2016 | 2761 | 0.070 |
Why?
|
| Adenocarcinoma | 1 | 2005 | 6364 | 0.070 |
Why?
|
| Rheology | 1 | 2009 | 348 | 0.070 |
Why?
|
| Histocompatibility | 3 | 2004 | 327 | 0.070 |
Why?
|
| Blood Coagulation Disorders | 2 | 2000 | 349 | 0.070 |
Why?
|
| Cell Transplantation | 2 | 2018 | 473 | 0.070 |
Why?
|
| Solubility | 1 | 2008 | 1078 | 0.070 |
Why?
|
| Lymphoma, Non-Hodgkin | 2 | 2008 | 1376 | 0.070 |
Why?
|
| Swine | 9 | 2002 | 5988 | 0.070 |
Why?
|
| Swine, Miniature | 4 | 2002 | 971 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2019 | 2567 | 0.070 |
Why?
|
| Cytokines | 7 | 2022 | 7421 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 1 | 1995 | 1880 | 0.070 |
Why?
|
| Receptors, Chemokine | 2 | 2008 | 651 | 0.070 |
Why?
|
| Hyperglycemia | 1 | 2015 | 1393 | 0.070 |
Why?
|
| Sialyltransferases | 1 | 2006 | 83 | 0.070 |
Why?
|
| Nitroimidazoles | 1 | 2007 | 117 | 0.060 |
Why?
|
| CD8-Positive T-Lymphocytes | 2 | 2014 | 4642 | 0.060 |
Why?
|
| Tumor Cells, Cultured | 3 | 2000 | 6113 | 0.060 |
Why?
|
| Lymphocyte Transfusion | 2 | 2005 | 236 | 0.060 |
Why?
|
| Leukemia, Myeloid | 2 | 2000 | 696 | 0.060 |
Why?
|
| Chemokines, CC | 1 | 2006 | 285 | 0.060 |
Why?
|
| Antigens, CD | 2 | 2002 | 4025 | 0.060 |
Why?
|
| Signal Transduction | 5 | 2019 | 23601 | 0.060 |
Why?
|
| Cell Proliferation | 5 | 2021 | 10429 | 0.060 |
Why?
|
| Microscopy, Video | 1 | 2006 | 241 | 0.060 |
Why?
|
| CD40 Ligand | 3 | 2002 | 528 | 0.060 |
Why?
|
| Triazines | 1 | 2007 | 307 | 0.060 |
Why?
|
| Perfusion | 2 | 2007 | 1407 | 0.060 |
Why?
|
| Adipose Tissue | 1 | 2017 | 3312 | 0.060 |
Why?
|
| RNA, Small Interfering | 2 | 2011 | 3421 | 0.060 |
Why?
|
| Pneumonia | 1 | 2016 | 2157 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2009 | 702 | 0.060 |
Why?
|
| Protein Structure, Tertiary | 1 | 2011 | 3750 | 0.060 |
Why?
|
| Multiple Myeloma | 4 | 2008 | 5197 | 0.060 |
Why?
|
| Enzyme Precursors | 1 | 1984 | 164 | 0.060 |
Why?
|
| Stem Cell Transplantation | 2 | 2010 | 1602 | 0.060 |
Why?
|
| Stem Cell Niche | 2 | 2019 | 346 | 0.060 |
Why?
|
| Carbohydrate Sequence | 2 | 2002 | 410 | 0.050 |
Why?
|
| Protein Isoforms | 2 | 2005 | 1718 | 0.050 |
Why?
|
| Mycophenolic Acid | 2 | 2002 | 346 | 0.050 |
Why?
|
| Blood Cell Count | 1 | 2004 | 405 | 0.050 |
Why?
|
| Anti-Inflammatory Agents | 2 | 2024 | 1808 | 0.050 |
Why?
|
| Swainsonine | 1 | 2002 | 9 | 0.050 |
Why?
|
| Th1 Cells | 1 | 2008 | 1039 | 0.050 |
Why?
|
| Oxidative Stress | 1 | 2014 | 3141 | 0.050 |
Why?
|
| von Willebrand Factor | 2 | 2011 | 676 | 0.050 |
Why?
|
| Tunicamycin | 1 | 2002 | 107 | 0.050 |
Why?
|
| Integrin alpha5beta1 | 1 | 2002 | 36 | 0.050 |
Why?
|
| Leydig Cells | 1 | 2022 | 55 | 0.050 |
Why?
|
| Interleukin-1 | 1 | 2006 | 1243 | 0.050 |
Why?
|
| Hemorheology | 1 | 2002 | 144 | 0.050 |
Why?
|
| Lymphopoiesis | 1 | 2002 | 132 | 0.050 |
Why?
|
| Schizophrenia | 1 | 2020 | 6972 | 0.050 |
Why?
|
| Kidney Transplantation | 3 | 2002 | 4270 | 0.050 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2001 | 123 | 0.050 |
Why?
|
| Bromelains | 1 | 2000 | 9 | 0.050 |
Why?
|
| Leukapheresis | 4 | 2002 | 150 | 0.040 |
Why?
|
| Precipitin Tests | 1 | 2001 | 812 | 0.040 |
Why?
|
| Genes | 2 | 1984 | 1825 | 0.040 |
Why?
|
| Killer Cells, Natural | 2 | 2008 | 2210 | 0.040 |
Why?
|
| Anthelmintics | 1 | 2021 | 83 | 0.040 |
Why?
|
| Male | 23 | 2022 | 363698 | 0.040 |
Why?
|
| rho-Associated Kinases | 1 | 2022 | 291 | 0.040 |
Why?
|
| Carbohydrate Conformation | 1 | 2000 | 206 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 1993 | 4913 | 0.040 |
Why?
|
| Glycoside Hydrolases | 1 | 2000 | 135 | 0.040 |
Why?
|
| Epithelial Cells | 1 | 2012 | 3681 | 0.040 |
Why?
|
| Hodgkin Disease | 1 | 2008 | 1383 | 0.040 |
Why?
|
| Biopsy | 2 | 2020 | 6763 | 0.040 |
Why?
|
| Brain Neoplasms | 1 | 2021 | 9071 | 0.040 |
Why?
|
| Survival Analysis | 5 | 2004 | 10070 | 0.040 |
Why?
|
| Pneumocystis | 1 | 1999 | 55 | 0.040 |
Why?
|
| Adult | 18 | 2021 | 223044 | 0.040 |
Why?
|
| Anti-HIV Agents | 2 | 2009 | 4559 | 0.040 |
Why?
|
| Naphthoquinones | 1 | 1999 | 61 | 0.040 |
Why?
|
| K562 Cells | 1 | 2001 | 649 | 0.040 |
Why?
|
| Florida | 1 | 2021 | 416 | 0.040 |
Why?
|
| Waldenstrom Macroglobulinemia | 1 | 2008 | 1076 | 0.040 |
Why?
|
| Disease Models, Animal | 4 | 2020 | 18293 | 0.040 |
Why?
|
| Blood Coagulation Factors | 1 | 2001 | 371 | 0.040 |
Why?
|
| Kidney Failure, Chronic | 2 | 2002 | 2495 | 0.040 |
Why?
|
| Metalloendopeptidases | 1 | 2000 | 386 | 0.040 |
Why?
|
| Medically Underserved Area | 1 | 2021 | 266 | 0.040 |
Why?
|
| Receptors, Fibroblast Growth Factor | 1 | 2019 | 192 | 0.040 |
Why?
|
| Thymus Gland | 3 | 2003 | 1261 | 0.040 |
Why?
|
| Antineoplastic Agents | 1 | 2021 | 13648 | 0.040 |
Why?
|
| Disease-Free Survival | 3 | 2004 | 6832 | 0.040 |
Why?
|
| Megakaryocytes | 1 | 2022 | 557 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2001 | 592 | 0.040 |
Why?
|
| Consumer Health Information | 1 | 2021 | 215 | 0.040 |
Why?
|
| Sialoglycoproteins | 1 | 2019 | 313 | 0.040 |
Why?
|
| Pneumonia, Pneumocystis | 1 | 1999 | 239 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2003 | 1250 | 0.040 |
Why?
|
| Graft Survival | 3 | 2004 | 3890 | 0.040 |
Why?
|
| Phylogeny | 1 | 1985 | 2832 | 0.040 |
Why?
|
| Middle Aged | 20 | 2021 | 223009 | 0.040 |
Why?
|
| Lung | 2 | 2016 | 10033 | 0.040 |
Why?
|
| Models, Animal | 2 | 2001 | 2120 | 0.040 |
Why?
|
| Chlorates | 1 | 1997 | 12 | 0.040 |
Why?
|
| Fusion Proteins, bcr-abl | 1 | 1999 | 430 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2002 | 17594 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 10729 | 0.040 |
Why?
|
| Hepatic Veno-Occlusive Disease | 1 | 1999 | 221 | 0.040 |
Why?
|
| Leukocyte Transfusion | 3 | 2003 | 58 | 0.040 |
Why?
|
| Hemodynamics | 1 | 2008 | 4184 | 0.040 |
Why?
|
| Graft Rejection | 4 | 2005 | 4499 | 0.040 |
Why?
|
| Female | 23 | 2021 | 396112 | 0.030 |
Why?
|
| Sialomucins | 1 | 1997 | 18 | 0.030 |
Why?
|
| Steroids | 1 | 2002 | 933 | 0.030 |
Why?
|
| Protein Biosynthesis | 1 | 1984 | 2086 | 0.030 |
Why?
|
| Salvage Therapy | 2 | 2001 | 1272 | 0.030 |
Why?
|
| Paraffin Embedding | 1 | 2018 | 301 | 0.030 |
Why?
|
| Polymorphism, Genetic | 2 | 1985 | 4247 | 0.030 |
Why?
|
| MAP Kinase Signaling System | 2 | 2018 | 1490 | 0.030 |
Why?
|
| Platelet Activation | 1 | 2000 | 645 | 0.030 |
Why?
|
| Pacemaker, Artificial | 2 | 1993 | 827 | 0.030 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2016 | 58 | 0.030 |
Why?
|
| Microcirculation | 1 | 2001 | 1280 | 0.030 |
Why?
|
| DNA | 3 | 1985 | 7202 | 0.030 |
Why?
|
| Th2 Cells | 1 | 2001 | 1075 | 0.030 |
Why?
|
| Cloning, Molecular | 4 | 1985 | 4165 | 0.030 |
Why?
|
| Sulfates | 1 | 1997 | 376 | 0.030 |
Why?
|
| Community Health Services | 1 | 2021 | 657 | 0.030 |
Why?
|
| Transcription Factors | 1 | 2015 | 12131 | 0.030 |
Why?
|
| ADAM Proteins | 2 | 2011 | 242 | 0.030 |
Why?
|
| Cell Line, Transformed | 1 | 1997 | 858 | 0.030 |
Why?
|
| Base Sequence | 4 | 2008 | 12403 | 0.030 |
Why?
|
| Whole-Body Irradiation | 3 | 2000 | 438 | 0.030 |
Why?
|
| Peritoneum | 1 | 2016 | 224 | 0.030 |
Why?
|
| Microscopy, Confocal | 1 | 2001 | 1966 | 0.030 |
Why?
|
| Oxygen | 1 | 2007 | 4241 | 0.030 |
Why?
|
| Interleukin-3 | 3 | 2002 | 423 | 0.030 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 4 | 2000 | 11868 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 1997 | 1061 | 0.030 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2017 | 394 | 0.030 |
Why?
|
| Antigens, CD1d | 2 | 2008 | 226 | 0.030 |
Why?
|
| Cyclophosphamide | 4 | 2003 | 2228 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2001 | 4562 | 0.030 |
Why?
|
| Antifungal Agents | 1 | 1999 | 769 | 0.030 |
Why?
|
| Blood Coagulation | 1 | 2000 | 1166 | 0.030 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 21056 | 0.030 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 1996 | 196 | 0.030 |
Why?
|
| Drug Approval | 1 | 2021 | 818 | 0.030 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 752 | 0.030 |
Why?
|
| Skin Diseases | 1 | 2002 | 1088 | 0.030 |
Why?
|
| Treatment Outcome | 9 | 2018 | 65188 | 0.030 |
Why?
|
| Leptin | 1 | 2022 | 1596 | 0.030 |
Why?
|
| Rats | 3 | 1997 | 23707 | 0.030 |
Why?
|
| Lymphoma | 1 | 2002 | 1897 | 0.030 |
Why?
|
| Blotting, Northern | 1 | 1995 | 1546 | 0.030 |
Why?
|
| Brain | 1 | 2020 | 27171 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2019 | 1744 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2000 | 3946 | 0.030 |
Why?
|
| Health Services Needs and Demand | 1 | 2021 | 1406 | 0.030 |
Why?
|
| United States Food and Drug Administration | 1 | 2021 | 1672 | 0.030 |
Why?
|
| Lymphocyte Count | 1 | 1995 | 790 | 0.030 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2016 | 1132 | 0.030 |
Why?
|
| Young Adult | 2 | 2021 | 59889 | 0.020 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2014 | 2878 | 0.020 |
Why?
|
| Renal Insufficiency | 1 | 1997 | 804 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2001 | 2080 | 0.020 |
Why?
|
| Mice, Inbred Strains | 2 | 1984 | 1770 | 0.020 |
Why?
|
| Inflammation Mediators | 1 | 2020 | 1884 | 0.020 |
Why?
|
| HLA Antigens | 3 | 2003 | 1339 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2001 | 6309 | 0.020 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2011 | 144 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2020 | 2589 | 0.020 |
Why?
|
| Testosterone | 1 | 2022 | 2494 | 0.020 |
Why?
|
| Blood Preservation | 1 | 2011 | 168 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2019 | 3608 | 0.020 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 2001 | 511 | 0.020 |
Why?
|
| Tissue Donors | 1 | 2020 | 2395 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 1995 | 13400 | 0.020 |
Why?
|
| Neoplasm Invasiveness | 1 | 2018 | 3602 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2021 | 2822 | 0.020 |
Why?
|
| Stem Cell Factor | 2 | 2000 | 194 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 2 | 2001 | 412 | 0.020 |
Why?
|
| Hymecromone | 1 | 2009 | 9 | 0.020 |
Why?
|
| Macrophages | 1 | 1984 | 5772 | 0.020 |
Why?
|
| Nanoparticles | 1 | 2021 | 1964 | 0.020 |
Why?
|
| Combined Modality Therapy | 5 | 2000 | 8529 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2006 | 8923 | 0.020 |
Why?
|
| Histocompatibility Testing | 2 | 2002 | 726 | 0.020 |
Why?
|
| Splenectomy | 2 | 2000 | 390 | 0.020 |
Why?
|
| Respiratory Muscles | 1 | 2009 | 144 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2021 | 3110 | 0.020 |
Why?
|
| Macaca fascicularis | 2 | 2000 | 907 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2021 | 3946 | 0.020 |
Why?
|
| United States | 2 | 2021 | 72903 | 0.020 |
Why?
|
| Registries | 1 | 2004 | 8297 | 0.020 |
Why?
|
| Integrins | 1 | 2012 | 840 | 0.020 |
Why?
|
| Dermatitis | 1 | 1989 | 199 | 0.020 |
Why?
|
| Cyclosporine | 2 | 2000 | 778 | 0.020 |
Why?
|
| Immunohistochemistry | 2 | 2018 | 11022 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 2 | 1984 | 548 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2004 | 10383 | 0.020 |
Why?
|
| Hematopoietic System | 1 | 2007 | 110 | 0.020 |
Why?
|
| Time Factors | 4 | 2002 | 40065 | 0.020 |
Why?
|
| Lymphoid Tissue | 1 | 1988 | 444 | 0.020 |
Why?
|
| Remission Induction | 2 | 2005 | 2411 | 0.020 |
Why?
|
| Heart Transplantation | 1 | 2000 | 3310 | 0.020 |
Why?
|
| Epidermis | 1 | 1989 | 538 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2004 | 22223 | 0.020 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1996 | 1434 | 0.020 |
Why?
|
| Complement C2 | 1 | 1985 | 41 | 0.020 |
Why?
|
| Enzyme Activation | 1 | 2011 | 3586 | 0.020 |
Why?
|
| Antibody Formation | 2 | 2000 | 1391 | 0.020 |
Why?
|
| Signal Processing, Computer-Assisted | 1 | 1992 | 1456 | 0.020 |
Why?
|
| NF-kappa B | 1 | 2014 | 2485 | 0.020 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2017 | 1883 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2014 | 2453 | 0.020 |
Why?
|
| Aged | 8 | 2021 | 171117 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2014 | 6220 | 0.010 |
Why?
|
| Collodion | 1 | 1984 | 33 | 0.010 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1993 | 1568 | 0.010 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1984 | 204 | 0.010 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2008 | 891 | 0.010 |
Why?
|
| Haplotypes | 2 | 2002 | 2728 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1989 | 1102 | 0.010 |
Why?
|
| Child | 2 | 2021 | 80564 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 8102 | 0.010 |
Why?
|
| Tachycardia, Ventricular | 1 | 1993 | 1310 | 0.010 |
Why?
|
| Autoradiography | 1 | 1984 | 723 | 0.010 |
Why?
|
| Protozoan Infections | 1 | 2003 | 39 | 0.010 |
Why?
|
| H-2 Antigens | 1 | 1984 | 359 | 0.010 |
Why?
|
| Defibrillators, Implantable | 1 | 1993 | 1490 | 0.010 |
Why?
|
| Trachea | 1 | 2009 | 1085 | 0.010 |
Why?
|
| Transcription, Genetic | 2 | 1995 | 7599 | 0.010 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2018 | 3646 | 0.010 |
Why?
|
| Cell Separation | 1 | 2008 | 1718 | 0.010 |
Why?
|
| Reference Values | 1 | 1989 | 4908 | 0.010 |
Why?
|
| Trisaccharides | 1 | 2002 | 50 | 0.010 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 2002 | 98 | 0.010 |
Why?
|
| Receptors, Immunologic | 1 | 1988 | 1415 | 0.010 |
Why?
|
| NK Cell Lectin-Like Receptor Subfamily B | 1 | 2001 | 85 | 0.010 |
Why?
|
| Benzimidazoles | 1 | 2007 | 864 | 0.010 |
Why?
|
| Colony-Forming Units Assay | 1 | 2002 | 351 | 0.010 |
Why?
|
| Lymphocyte Subsets | 1 | 2002 | 315 | 0.010 |
Why?
|
| Macrophage Activation | 1 | 1984 | 552 | 0.010 |
Why?
|
| Aspergillosis | 1 | 2003 | 242 | 0.010 |
Why?
|
| Gram-Negative Bacterial Infections | 1 | 2003 | 239 | 0.010 |
Why?
|
| Platelet Count | 1 | 2004 | 782 | 0.010 |
Why?
|
| Elapid Venoms | 1 | 2000 | 39 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 1 | 2001 | 251 | 0.010 |
Why?
|
| Pandemics | 1 | 2021 | 8703 | 0.010 |
Why?
|
| Complement Inactivator Proteins | 1 | 2000 | 67 | 0.010 |
Why?
|
| Radionuclide Imaging | 1 | 2005 | 1978 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15880 | 0.010 |
Why?
|
| Phenotype | 3 | 2000 | 16721 | 0.010 |
Why?
|
| Graft Enhancement, Immunologic | 1 | 2000 | 58 | 0.010 |
Why?
|
| Models, Biological | 1 | 2016 | 9443 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1997 | 7851 | 0.010 |
Why?
|
| Atovaquone | 1 | 1999 | 56 | 0.010 |
Why?
|
| Leukocyte Count | 1 | 2004 | 1602 | 0.010 |
Why?
|
| Graft vs Leukemia Effect | 1 | 2000 | 122 | 0.010 |
Why?
|
| RNA Interference | 1 | 2008 | 2832 | 0.010 |
Why?
|
| Species Specificity | 1 | 1984 | 2406 | 0.010 |
Why?
|
| Electrocardiography | 1 | 1992 | 6404 | 0.010 |
Why?
|
| Recombinant Proteins | 2 | 2000 | 6493 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2005 | 2505 | 0.010 |
Why?
|
| Adolescent | 3 | 2021 | 88835 | 0.010 |
Why?
|
| Software | 1 | 1992 | 4462 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 1984 | 2341 | 0.010 |
Why?
|
| Chimera | 1 | 1999 | 455 | 0.010 |
Why?
|
| Platelet Aggregation | 1 | 2001 | 769 | 0.010 |
Why?
|
| Antilymphocyte Serum | 1 | 2000 | 493 | 0.010 |
Why?
|
| Survival Rate | 2 | 2008 | 12795 | 0.010 |
Why?
|
| Neutropenia | 1 | 2003 | 893 | 0.010 |
Why?
|
| Blood | 1 | 2000 | 597 | 0.010 |
Why?
|
| Virus Diseases | 1 | 2003 | 718 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1996 | 5849 | 0.010 |
Why?
|
| Carboplatin | 1 | 2000 | 789 | 0.010 |
Why?
|
| Busulfan | 1 | 1997 | 264 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2003 | 1789 | 0.010 |
Why?
|
| Transplantation Tolerance | 1 | 2000 | 640 | 0.010 |
Why?
|
| HeLa Cells | 1 | 2001 | 3067 | 0.010 |
Why?
|
| Receptors, Cytokine | 1 | 1996 | 258 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 6203 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 4475 | 0.010 |
Why?
|
| Morbidity | 1 | 2000 | 1749 | 0.010 |
Why?
|
| Living Donors | 1 | 1999 | 645 | 0.010 |
Why?
|
| RNA | 1 | 1984 | 2717 | 0.010 |
Why?
|
| Immunity, Cellular | 1 | 2000 | 1555 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1989 | 9347 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 3737 | 0.010 |
Why?
|
| Atrial Fibrillation | 1 | 1992 | 5189 | 0.010 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 1997 | 614 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2020 | 36532 | 0.010 |
Why?
|
| Alleles | 1 | 1984 | 6897 | 0.010 |
Why?
|
| Atrioventricular Node | 1 | 1992 | 180 | 0.010 |
Why?
|
| Retrospective Studies | 4 | 2004 | 81514 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1999 | 2844 | 0.010 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2001 | 2770 | 0.000 |
Why?
|
| Mortality | 1 | 2000 | 2904 | 0.000 |
Why?
|
| Heart Diseases | 1 | 2000 | 2821 | 0.000 |
Why?
|
| Clinical Trials as Topic | 1 | 2002 | 8041 | 0.000 |
Why?
|
| Genotype | 1 | 2000 | 13024 | 0.000 |
Why?
|
| Follow-Up Studies | 2 | 2000 | 39193 | 0.000 |
Why?
|
| Equipment Design | 1 | 1993 | 3481 | 0.000 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2000 | 5337 | 0.000 |
Why?
|
| Hemolysis | 1 | 1984 | 406 | 0.000 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 20124 | 0.000 |
Why?
|
| Cohort Studies | 1 | 2003 | 41649 | 0.000 |
Why?
|
| Catheter Ablation | 1 | 1992 | 2788 | 0.000 |
Why?
|
| Postoperative Complications | 1 | 2000 | 15747 | 0.000 |
Why?
|
| Prospective Studies | 1 | 1999 | 54802 | 0.000 |
Why?
|
| Risk Factors | 1 | 1992 | 74840 | 0.000 |
Why?
|